Boston Scientific Receives FDA Approval for Next-Generation WATCBSX: Boston Scientific Corporation
2020-07-21 16:24:00
Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device
4BSX trade ideas
Bullish Charts - Golden CrossBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Daily Chart - Golden Cross
Stochastic is moving up, Bullish
RSI is crossing center line, Bullish
Volume just went green on the daily
I think the stock is getting ready to move higher.
I also think, BSX is one of the cheapest medical device companies in the industry.
Long
Big Potential to BOSTON SCIENTIFIC CORPHello people, BOSTON SCIENTIFIC CORP is really in an important moment, possibility that it goes higher than expected, see how the stabilization zone of the last two days breaks.
Please LIKE & FOLLOW, thank you!
There's Nothing Scientific about a Momentum Burst!What I see...
+ MACD is cutting upward in bullish zone
+ RSI is rising at 56.8
+ Nice hammer ended the week at just under the top of the channel
+ Prices have been range-bounded in the past 2 months
+ Very high vol. -2w
+ NR7 on -1d
:: I would like the prices to move sideway for a bit longer to wait for the 10ma to pull up
:: I'm setting up an entry just in case it breaks out with little warning
- Price has drifted a bit away from the 10ma
- First Resistance at range high set in mid-April; Second Resistance at 200ma
- It's been multiple up days in a row
What I setup
+ Long entry above range
- Stop at bottom of the doji on -1d
+ Target at 44
:: Duration - months
** Comments and Likes are appreciated; New Subscribers are scientific! **
$BSX Nice big wedge starting to break out.Plenty of recent buy volume, along with a big wedge starting to break through, looks good.
Long Idea: Breakout Based6/Sep/2019 10:27 AM
--
Breaking out of multi month darvas box here.
Long timeframe idea. No price projections but one could use fib extensions to generate some if desired.
Stop is half way of the range we are breaking out of.
No position
======================
Boston Scientific Announces FDA Approval Of ImageReady(TM) MRI FBSX: Boston Scientific Corporation
2019-08-19 17:39:00
Boston Scientific Announces FDA Approval Of ImageReady(TM) MRI For Vercise Gevia(TM) Deep Brain Stimulation System
Short the Red box :OWe have a good shorting Opp here. Its showing signs of reversal on most timeframes especially the larger ones such at the Month, Week and Daily.
Noone can see 3-4 years into the future right? Well I'm no different so dont take this as financial advice more of just a hey this looks ok to me sort of thing. Ive taken the time to give you a Fan, a Triangle, and major resistance and support levels on larger time frames. Take the time do your own research but hope this helps guide some in the right direction Enjoy :)
Purple is Monthy
Yellow is weekly
White is Heavy resistance/support lines due to large moves up/down
Red Box: Short Area
Overall Target it is 18-19, with potential to break through to 7-8
$BSX BOSTON SCIENTIFIC HAS TROUBLE AHEAD.Yesterdays enforcement by the FDA for BSX to remove one of its products from the market is a significant blow to BSX and has sent investors running scared. Fears from legal actions by clients are a definite and real possibility which will send the price into further correction in out opinion.
Apr 18 - BSXBSX 18-Apr-19
IV30: 30.6, IVR: 76% (Elevated)
Bear Call Spread / Call Credit Spread
+0.26D Long 1 Call: 42 Strike @ $0.50
-0.36D Short 1 Call: 41 Strike @ $0.77
-0.10D Credit: $0.27
Highest OI at 45 Strike
Boston Scientific Receives U.S. FDA Approval for the Eluvia™ BSX: Boston Scientific
2018-09-24 06:45:00
Boston Scientific Receives U.S. FDA Approval for the Eluvia™ Drug-Eluting Vascular Stent System
